Three in four AI-listed devices are in the radiology panel; its share peaked in 2020
Share of each year's devices on the FDA's AI-Enabled Medical Device List by the lead panel the list gives each device, by year of final decision, 2016 to June 2026
Show the numbers as a table
| Period | Series | Share of the year's devices | Note |
|---|---|---|---|
| 2016 | Radiology | 61.11% | 11 of 18 devices |
| 2016 | Cardiovascular | 22.22% | 4 of 18 devices |
| 2016 | Neurology | 5.56% | 1 of 18 devices |
| 2016 | All other panels | 11.11% | 2 of 18 devices |
| 2017 | Radiology | 59.26% | 16 of 27 devices |
| 2017 | Cardiovascular | 25.93% | 7 of 27 devices |
| 2017 | Neurology | 0.0% | 0 of 27 devices |
| 2017 | All other panels | 14.81% | 4 of 27 devices |
| 2018 | Radiology | 61.54% | 40 of 65 devices |
| 2018 | Cardiovascular | 15.38% | 10 of 65 devices |
| 2018 | Neurology | 9.23% | 6 of 65 devices |
| 2018 | All other panels | 13.85% | 9 of 65 devices |
| 2019 | Radiology | 63.75% | 51 of 80 devices |
| 2019 | Cardiovascular | 18.75% | 15 of 80 devices |
| 2019 | Neurology | 6.25% | 5 of 80 devices |
| 2019 | All other panels | 11.25% | 9 of 80 devices |
| 2020 | Radiology | 86.84% | 99 of 114 devices |
| 2020 | Cardiovascular | 7.02% | 8 of 114 devices |
| 2020 | Neurology | 0.88% | 1 of 114 devices |
| 2020 | All other panels | 5.26% | 6 of 114 devices |
| 2021 | Radiology | 85.27% | 110 of 129 devices |
| 2021 | Cardiovascular | 8.53% | 11 of 129 devices |
| 2021 | Neurology | 2.33% | 3 of 129 devices |
| 2021 | All other panels | 3.88% | 5 of 129 devices |
| 2022 | Radiology | 85.19% | 138 of 162 devices |
| 2022 | Cardiovascular | 8.64% | 14 of 162 devices |
| 2022 | Neurology | 1.23% | 2 of 162 devices |
| 2022 | All other panels | 4.94% | 8 of 162 devices |
| 2023 | Radiology | 78.76% | 178 of 226 devices |
| 2023 | Cardiovascular | 9.29% | 21 of 226 devices |
| 2023 | Neurology | 4.87% | 11 of 226 devices |
| 2023 | All other panels | 7.08% | 16 of 226 devices |
| 2024 | Radiology | 77.87% | 183 of 235 devices |
| 2024 | Cardiovascular | 6.38% | 15 of 235 devices |
| 2024 | Neurology | 6.38% | 15 of 235 devices |
| 2024 | All other panels | 9.36% | 22 of 235 devices |
| 2025 | Radiology | 75.82% | 254 of 335 devices |
| 2025 | Cardiovascular | 8.96% | 30 of 335 devices |
| 2025 | Neurology | 5.67% | 19 of 335 devices |
| 2025 | All other panels | 9.55% | 32 of 335 devices |
| Jan to Jun 2026 | Radiology | 74.59% | 135 of 181 devices |
| Jan to Jun 2026 | Cardiovascular | 8.29% | 15 of 181 devices |
| Jan to Jun 2026 | Neurology | 4.42% | 8 of 181 devices |
| Jan to Jun 2026 | All other panels | 12.71% | 23 of 181 devices |
About the data
- Source
- FDA, Artificial Intelligence-Enabled Medical Devices (opens in a new tab)The list (CSV), content current as of September 4, 2026: Date of Final Decision, Submission Number, Panel (Lead), Primary Product Code
- Method
- Kent Applied joined each device on the FDA's AI-Enabled Medical Device List (the version current as of September 4, 2026: 1,614 devices with final decisions from September 29, 1995, to June 29, 2026) to its record in the FDA's 510(k), PMA and product classification files by submission number. The FDA says the list is not a comprehensive resource of AI-enabled devices. The panel is the list's "Panel (Lead)" field, the FDA's medical specialty grouping for the type of device, so it describes the device type and not the doctors who use it. All other panels covers 15: Anesthesiology, Gastroenterology-Urology, Hematology, Pathology, Ophthalmic, General and Plastic Surgery, Clinical Chemistry, Orthopedic, Dental, Microbiology, General Hospital, Obstetrics and Gynecology, Clinical Toxicology, Ear Nose & Throat, Immunology. 2026 runs from January to June.
- Published
Free to share and embed with credit to Kent Applied (CC BY 4.0). The source data keeps its own terms.
Related charts
- From research
About one FDA 510(k) clearance in ten is now for a device on the AI list
FDA, Artificial Intelligence-Enabled Medical Devices; FDA, 510(k) releasable files - From research
More than half of the FDA's 2025 clearances tagged radiology were for AI-listed devices
FDA, Artificial Intelligence-Enabled Medical Devices; FDA, 510(k) releasable files - From research
A quarter of the devices on the FDA's AI list are filed under scanner product codes
FDA, Artificial Intelligence-Enabled Medical Devices; FDA, product classification file - From research
40 devices on the FDA's AI list came through De Novo grants, each a new device type
FDA, Artificial Intelligence-Enabled Medical Devices; FDA, product classification file; FDA, De Novo Classification Request
Sources for the figures above: FDA, De Novo Classification Request (opens in a new tab).
Book a 20-minute call
Tyler Kent can measure a question like this one in your own data. Start with a short call.
Prefer to skip the call? Get a written proposal
Or email tyler@kentapplied.com.